EUVIMEDEUVIMED entdecken
Crossref

2089-P: Hemoglobin A1c Trajectories from Diabetes Onset in Youth with Type 2 Diabetes (T2D)

ANNA KADI, DANIEL PALACIOS, SUKRU ARAS, LYDIA SOBHI, HU CHEN, ZHANDONG LIU, MARIA J. REDONDO, MUSTAFA TOSUR

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2089-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ANNA KADI und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Distinct A1c trajectories in youth with type 1 diabetes are associated with specific outcomes. Whether such trajectories exist in youth with T2D is unknown. We aimed to identify A1c trajectories after T2D onset in youth.

Methods

Youth with T2D aged 8-20 years and diagnosed between 2011 and 2025 were identified from electronic medical records at a tertiary care center. Clustering analysis using A1c trajectory features (baseline, mean, slope, and change) identified patterns over 5 years after diagnosis. Demographic and clinical characteristics were compared across trajectories, and multivariable regression analyses identified predictors of diabetic complications.

Results

The cohort included 2,449 youth (41.8% male, 58.3% Hispanic, 28.1% African American) with mean A1c at diagnosis of 8.7%. Three A1c trajectories were identified (Figure). Compared to the low A1c trajectory, the intermediate and high trajectories included higher proportions of African American and male youth (p<0.001, both). Youth in these trajectories were more likely to require insulin at 2 and 5 years after diagnosis (p<0.001, both). Belonging to the high A1c trajectory was among the strongest predictors of diabetic ketoacidosis.

Conclusion

Distinct A1c trajectories occur after T2D onset in youth and are associated with demographic and clinical differences. Early identification of high-risk youth may help guide monitoring and targeted interventions. Disclosure A. Kadi: None. D. Palacios: None. S. Aras: None. L. Sobhi: None. H. Chen: None. Z. Liu: None. M.J. Redondo: Advisory Panel; Current; Sanofi. Other - Data Safety Monitoring committee; Current; Lilly. M. Tosur: None. Funding National Institutes of Health (3 U24 DK097771-12S1)

Zitieren

APA

KADI, A., PALACIOS, D., ARAS, S., SOBHI, L., CHEN, H., LIU, Z., REDONDO, M. J., & TOSUR, M. (2026). 2089-P: Hemoglobin A1c Trajectories from Diabetes Onset in Youth with Type 2 Diabetes (T2D). Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2089-p

Vancouver

KADI A, PALACIOS D, ARAS S, SOBHI L, CHEN H, LIU Z, et al. 2089-P: Hemoglobin A1c Trajectories from Diabetes Onset in Youth with Type 2 Diabetes (T2D). Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2089-p

BibTeX
@article{KADI2026,
  author = {KADI, ANNA and PALACIOS, DANIEL and ARAS, SUKRU and SOBHI, LYDIA and CHEN, HU and LIU, ZHANDONG and REDONDO, MARIA J. and TOSUR, MUSTAFA},
  title = {2089-P: Hemoglobin A1c Trajectories from Diabetes Onset in Youth with Type 2 Diabetes (T2D)},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2089-p}
}
Kostenlos starten →